/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Safety and efficacy of induced pluripotent stem cell-derived engineered human myocardium as biological ventricular assist tissue in term. heart failure (BioVAT-HF):trial design and experience at UKSH
Event: Heart Failure 2023
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session: Heart failure with reduced ejection fraction (HFrEF) 3
Comparison 8 vs. 10mm fenestration size of the atrial flow regulator in patients with heart failure with reduced and preserved ejection fraction: an analysis of the Prelieve Trial
Event: Heart Failure 2022
Topic: Diastolic Ventricular Dysfunction
Session: Heart Failure ePosters - focus on Chronic Heart Failure 5
Feasibility of transcatheter procedures in patients with heart failure with reduced and preserved ejection fraction treated with the atrial flow regulator: a 3-D heart model
Event: Heart Failure 2022
Topic: Diastolic Ventricular Dysfunction
Session: Heart Failure ePosters - focus on Chronic Heart Failure 3
